Research institute
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients with the disease, according to a study at The University of Texas MD Anderson Cancer Center.
A two-year old patient at the Royal Manchester Children’s Hospital (RMCH) is the first in the world to receive a pioneering new ex vivogene therapy treatment using lentiviral vector-modified autologous stem cells for the rare and life-limiting genetic condition, Mucopolysaccharidosis IIIA (MPSIIIA).
Researchers with the Hubrecht Institute in Utrecht, Netherlands and Radboud University in Nijmegen, Netherlands, recently developed a human model using organoids to evaluate the function of specific genes commonly mutated in liver cancer.
Singapore-based researchers have discovered a possible solution to impede the evolution of bacteria into superbugs that are resistant to drugs and therefore harder to kill.
Researchers from Singapore have designed the world’s first ‘molecular swing’ to transport electrolytes across cell membranes.
Research Roundup for Friday, May 24.
A paper published by Tillman Gerngross, chief executive officer of Adimab LLC, alleged that an MIT professor’s work was nearly identical to work published several years before his.
The Integrated Mitotic Stem Cell merges images of 15 separate cellular components, creating a 3-dimensional map of what a human cell looks like during different steps in cell division. The idea is that it can assist researchers in better understanding how the separate stages and different components of the cell work together.
Joins MD Anderson from University Health Network/Princess Margaret Cancer Centre
The NIH program aims to recruit up to 15 investigators from diverse backgrounds each year and to provide the investigators with mentoring and other professional development activities.
PRESS RELEASES